Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Schreiber

Showing results (1-10 of 927) with videos related to

Pageof 93
Sort By:
Gastroenterology|November 16, 2005
Of mice and men: what to learn about human inflammatory bowel disease from genetic analysis of murine inflammationStefan Schreiber
Gastroenterology & Hepatology|May 7, 2014
Commentary: vedolizumab: a new mechanism of action for the treatment of ulcerative colitisStefan Schreiber
Zeitschrift Fur Gastroenterologie|March 31, 2015
[Statement of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) for teduglutide-benefit assessment according to § 35a SGB V the G-BA]Stefan Schreiber
Expert Review of Gastroenterology & Hepatology|September 24, 2015
An update on biosimilar drugs for inflammatory bowel diseaseStefan Schreiber
Therapeutic Advances in Gastroenterology|November 2, 2011
Certolizumab pegol for the treatment of Crohn's diseaseStefan Schreiber
Gastroenterology|May 9, 2009
The genetic universe of inflammatory bowel diseaseStefan Schreiber
Journal of Crohn'S & Colitis|February 11, 2020
Lack of Efficacy in Crohn's Disease Prompts Unplanned Interim Analysis and Termination of Study in Ulcerative ColitisStefan Schreiber
Drug Research|November 17, 2021
Stefan Schreiber
Gastroenterology|March 29, 2016
How Failure Can Fuel Improvements in Early Drug Development for Inflammatory Bowel DiseasesStefan Schreiber, Séverine Vermeire
European Journal of Gastroenterology & Hepatology|May 10, 2008
Expression signatures, barriers and beyond: the role of oxidative stress in murine colitis and human inflammatory bowel disease revisitedPhilip Rosenstiel, Stefan Schreiber
Pageof 93

Showing results (1-10 of 927) with videos related to

Sort By:
Pageof 93
Gastroenterology|November 16, 2005
Of mice and men: what to learn about human inflammatory bowel disease from genetic analysis of murine inflammationStefan Schreiber
Gastroenterology & Hepatology|May 7, 2014
Commentary: vedolizumab: a new mechanism of action for the treatment of ulcerative colitisStefan Schreiber
Zeitschrift Fur Gastroenterologie|March 31, 2015
[Statement of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) for teduglutide-benefit assessment according to § 35a SGB V the G-BA]Stefan Schreiber
Expert Review of Gastroenterology & Hepatology|September 24, 2015
An update on biosimilar drugs for inflammatory bowel diseaseStefan Schreiber
Therapeutic Advances in Gastroenterology|November 2, 2011
Certolizumab pegol for the treatment of Crohn's diseaseStefan Schreiber
Gastroenterology|May 9, 2009
The genetic universe of inflammatory bowel diseaseStefan Schreiber
Journal of Crohn'S & Colitis|February 11, 2020
Lack of Efficacy in Crohn's Disease Prompts Unplanned Interim Analysis and Termination of Study in Ulcerative ColitisStefan Schreiber
Drug Research|November 17, 2021
Stefan Schreiber
Gastroenterology|March 29, 2016
How Failure Can Fuel Improvements in Early Drug Development for Inflammatory Bowel DiseasesStefan Schreiber, Séverine Vermeire
European Journal of Gastroenterology & Hepatology|May 10, 2008
Expression signatures, barriers and beyond: the role of oxidative stress in murine colitis and human inflammatory bowel disease revisitedPhilip Rosenstiel, Stefan Schreiber
Pageof 93